Ticker Details
Lyell Immunopharma, Inc.
IPO Date:	June 17, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$454.62M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 4.16%
Avg Daily Range (30 D):	$0.63 | 2.63%
Avg Daily Range (90 D):	$0.91 | 3.74%

Institutional Daily Volume
Avg Daily Volume:	.21M
Avg Daily Volume (30 D):	.08M
Avg Daily Volume (90 D):	.06M

Trade Size
Avg Trade Size (Sh.):	41
Avg Trade Size (Sh.) (30 D):	50
Avg Trade Size (Sh.) (90 D):	45

Institutional Trades
Total Institutional Trades:	346
Avg Institutional Trade:	$1.97M
Avg Institutional Trade (30 D):	$.5M
Avg Institutional Trade (90 D):	$1.66M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.31M
Avg Closing Trade (30 D):	$3.02M
Avg Closing Trade (90 D):	$2.81M
Avg Closing Volume:	29.24K

News

Dec 9, 2025 @ 1:00 PM Century Therapeutics Appoints Accomplished Biotech... Source: Century Therapeutics

Dec 7, 2025 @ 9:30 PM Lyell Immunopharma Presents New Clinical Data from... Source: Lyell Immunopharma

Nov 3, 2025 @ 2:00 PM Lyell Announces Two Oral Presentations from the Ph... Source: Lyell Immunopharma, Inc.

Jul 29, 2025 @ 7:46 PM Biotech Underdogs Line Up for Pivotal Shots at Gam... Source: Prnewswire

Jun 23, 2025 @ 9:00 PM Lyell Immunopharma to Participate in the H.C. Wain... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$1.97	$-2.13	$-2.89
Diluted EPS	$1.97	$-2.13	$-2.89
Revenue	$.04M	$.02M	$.01M
Gross Profit
Net Income / Loss	$-325.66M	$-38.85M	$-42.68M
Operating Income / Loss	$-342.91M	$-37.25M	$-47.14M
Cost of Revenue
Net Cash Flow	$24.57M	$24.77M	$-21.63M
PE Ratio	11.71

Splits
Jun 02, 2025	1:20